RGPD3 Activators
RGPD3 Activators encompass a diverse range of chemical compounds that amplify the functional capacity of RGPD3 via distinct and specific signaling pathways. For instance, Forskolin and IBMX both operate by elevating intracellular cAMP levels, which indirectly potentiate RGPD3 activity by augmenting PKA signaling that may phosphorylate and modulate proteins associated with RGPD3. Similarly, PMA, as a PKC activator, and Ionomycin, functioning as a calcium ionophore, perturb the dynamic equilibrium of intracellular signaling, thus providing avenues for the heightened activity of RGPD3 through calcium-dependent and PKC-mediated pathways. Additionally, molecules like SNAP and Sildenafil, by increasing the pools of cGMP, potentially enhance RGPD3 activity by affecting downstream targets within these signaling cascades.
Further expanding the repertoire of RGPD3 activators, compounds such as A23187, EGCG, LY294002, and U0126 offer nuanced mechanisms to skew cellular signaling in favor of RGPD3 activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which could then phosphorylate and regulate proteins including RGPD3, thus potentially enhancing RGPD3's functional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which prevents cAMP breakdown, leading to increased PKA activity. This could indirectly enhance the activity of RGPD3 by promoting phosphorylation events. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that mimics diacylglycerol. PKC activation can lead to downstream effects that may include the phosphorylation and activation of proteins potentially interacting with RGPD3. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular Ca2+ levels, which can activate calcium-dependent signaling pathways and proteins that may interact with RGPD3 to enhance its activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that increases intracellular Ca2+ concentration, activating calcium-dependent proteins and pathways that might enhance the function of RGPD3. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that has been shown to inhibit certain protein kinases, which might reduce competitive signaling and indirectly enhance the pathways where RGPD3 is involved. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that changes AKT signaling, which could shift signaling homeostasis and potentially enhance RGPD3's activity through alternative pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK, potentially altering signaling cascades that could indirectly enhance the activity of RGPD3 through stress response pathways. | ||||||
2-Methoxyestradiol | 362-07-2 | sc-201371 sc-201371A | 10 mg 50 mg | $71.00 $288.00 | 6 | |
2-Methoxyestradiol inhibits microtubule polymerization, which could affect cell division and signal transduction pathways, potentially enhancing RGPD3's activity. | ||||||